These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 17137615
21. H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1. Magerl C, Ellinger J, Braunschweig T, Kremmer E, Koch LK, Höller T, Büttner R, Lüscher B, Gütgemann I. Hum Pathol; 2010 Feb; 41(2):181-9. PubMed ID: 19896696 [Abstract] [Full Text] [Related]
22. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Herawi M, Epstein JI. Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076 [Abstract] [Full Text] [Related]
24. HNF6 and HNF4α expression in adenocarcinomas of the liver, pancreaticobiliary tract, and gastrointestinal tract: an immunohistochemical study of 480 adenocarcinomas of the digestive system. Toriyama K, Uehara T, Iwakoshi A, Kawashima H, Hosoda W. Pathology; 2024 Oct; 56(6):804-813. PubMed ID: 38926048 [Abstract] [Full Text] [Related]
25. Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation. Soini Y, Takasawa A, Eskelinen M, Juvonen P, Kärjä V, Hasegawa T, Murata M, Tanaka S, Kojima T, Sawada N. J Clin Pathol; 2012 May; 65(5):431-6. PubMed ID: 22396552 [Abstract] [Full Text] [Related]
29. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM. Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [Abstract] [Full Text] [Related]
30. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L, Sanderson SO, Lloyd RV, Smyrk TC. Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [Abstract] [Full Text] [Related]
31. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM. Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [Abstract] [Full Text] [Related]
32. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Lee KM, Cao D, Itami A, Pour PM, Hruban RH, Maitra A, Ouellette MM. Histopathology; 2007 Oct; 51(4):539-46. PubMed ID: 17714470 [Abstract] [Full Text] [Related]
33. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters. Giannopoulos G, Pavlakis K, Parasi A, Kavatzas N, Tiniakos D, Karakosta A, Tzanakis N, Peros G. Anticancer Res; 2008 Oct; 28(3B):1875-81. PubMed ID: 18630474 [Abstract] [Full Text] [Related]
34. Nonneoplastic signet-ring cell change in gastrointestinal and biliary tracts: a pitfall for overdiagnosis. Dhingra S, Wang H. Ann Diagn Pathol; 2011 Dec; 15(6):490-6. PubMed ID: 22082777 [Abstract] [Full Text] [Related]
35. Common expression of the tumor marker D-galactose-beta-[1-->3]-N-acetyl-D-galactosamine by different adenocarcinomas: evidence of field effect phenomenon. Shamsuddin AM, Tyner GT, Yang GY. Cancer Res; 1995 Jan 01; 55(1):149-52. PubMed ID: 7805025 [Abstract] [Full Text] [Related]
36. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H. Clin Cancer Res; 2008 Nov 01; 14(21):7043-9. PubMed ID: 18981001 [Abstract] [Full Text] [Related]
37. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression. Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T, Shimamoto F, Hiyama E. J Surg Oncol; 2008 Apr 01; 97(5):469-75. PubMed ID: 18161862 [Abstract] [Full Text] [Related]
38. Cystic pancreatic endocrine tumor: a variant commonly confused with cystic adenocarcinoma. Deshpande V, Lauwers GY. Cancer; 2007 Feb 25; 111(1):47-53. PubMed ID: 17173321 [Abstract] [Full Text] [Related]
39. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract. Birbe R, Palazzo JP, Walters R, Weinberg D, Schulz S, Waldman SA. Hum Pathol; 2005 Feb 25; 36(2):170-9. PubMed ID: 15754294 [Abstract] [Full Text] [Related]
40. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J. Ann Surg Oncol; 2009 Aug 25; 16(8):2339-50. PubMed ID: 19475450 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]